PD Dr. Florian Putz

Department of Radiation Oncology

Investigation of Long Term Survival in Metastatic NSCLC with Driver Mutations under Molecular Targeted Therapy and Local Radiotherapy of all Tumor Manifestations (2019) Weissmann T, Semrau S, Lettmaier S, Fietkau R, Putz F Conference contribution FSRT versus SRS for Patients with large Brain Metastases: A volume-based Analysis of local Control and Radionecrosis (2019) Putz F, Oft D, Lettmaier S, Weissmann T, Fietkau R Conference contribution Results of Re-Chemoradiotherapy in Patients with relapsed Glioblastoma WHO IV (2019) Mansoorian S, Lettmaier S, Goerig N, Weissmann T, Semrau S, Fietkau R, Putz F Conference contribution Salivary gland carcinoma (SGC) with perineural spread and/or positive resection margin - High locoregional control rates after photon (chemo) radiotherapy - Experience from a monocentric analysis (2019) Haderlein M, Scherl C, Semrau S, Lettmaier S, Hecht M, Putz F, Iro H, et al. Journal article Fractionated stereotactic radiation therapy for adrenal metastases: contributing to local tumor control with low toxicity (2019) Burjakow K, Fietkau R, Putz F, Achterberg N, Lettmaier S, Knippen S Journal article Penile bulb sparing in prostate cancer radiotherapy: Dose analysis of an in-house MRI system to improve contouring (2019) Boeckelmann F, Hammon M, Lettmaier S, Fietkau R, Bert C, Putz F Journal article Paragangliomas of the Head and Neck: Local Control and Functional Outcome Following Fractionated Stereotactic Radiotherapy (2019) Weissmann T, Lettmaier S, Roesch J, Mengling V, Bert C, Iro H, Hornung J, et al. Journal article Predictors of long-term survival following radical treatment of oligometastatic NSCLC with cerebral metastases (2018) Hirschmann E, Zoske H, Weissmann T, Lettmaier S, Filimonova I, Fietkau R, Putz F Conference contribution Paragangliomas of the head and neck-local control and functional outcomes following stereotactic radiotherapy (2018) Weissmann T, Semrau S, Fietkau R, Putz F Conference contribution Pretreatment vitamin D levels are associated with improved overall survival following combined chemoradiotherapy (2018) Putz F, Distel L, Lettmaier S, Weissmann T, Filimonova I, Fietkau R Conference contribution